InflaRx NV (IFRX)
2.035
+0.32
(+19.01%)
USD |
NASDAQ |
Nov 14, 16:00
2.08
+0.04
(+2.21%)
After-Hours: 18:02
InflaRx Enterprise Value: 20.31M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 20.31M |
| November 12, 2024 | 8.531M |
| November 11, 2024 | 9.709M |
| November 08, 2024 | 11.48M |
| November 07, 2024 | 8.531M |
| November 06, 2024 | 9.709M |
| November 05, 2024 | 13.83M |
| November 04, 2024 | 11.48M |
| November 01, 2024 | 12.65M |
| October 31, 2024 | 10.89M |
| October 30, 2024 | 12.06M |
| October 29, 2024 | 11.77M |
| October 28, 2024 | 12.06M |
| October 25, 2024 | 12.06M |
| October 24, 2024 | 13.83M |
| October 23, 2024 | 7.354M |
| October 22, 2024 | 10.30M |
| October 21, 2024 | 9.709M |
| October 18, 2024 | 13.24M |
| October 17, 2024 | 10.89M |
| October 16, 2024 | 8.531M |
| October 15, 2024 | 6.765M |
| October 14, 2024 | 7.942M |
| October 11, 2024 | 8.531M |
| October 10, 2024 | 5.587M |
| Date | Value |
|---|---|
| October 09, 2024 | 6.765M |
| October 08, 2024 | 7.942M |
| October 07, 2024 | 9.709M |
| October 04, 2024 | 11.48M |
| October 03, 2024 | 11.48M |
| October 02, 2024 | 9.709M |
| October 01, 2024 | 8.531M |
| September 30, 2024 | 9.709M |
| September 27, 2024 | 12.06M |
| September 26, 2024 | 10.30M |
| September 25, 2024 | 9.12M |
| September 24, 2024 | 10.30M |
| September 23, 2024 | 6.765M |
| September 20, 2024 | 10.89M |
| September 19, 2024 | 9.12M |
| September 18, 2024 | 4.998M |
| September 17, 2024 | 4.409M |
| September 16, 2024 | 4.998M |
| September 13, 2024 | 3.820M |
| September 12, 2024 | 4.409M |
| September 11, 2024 | 5.587M |
| September 10, 2024 | 6.176M |
| September 09, 2024 | 9.709M |
| September 06, 2024 | 9.12M |
| September 05, 2024 | 12.06M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-88.64M
Minimum
Nov 15 2019
226.41M
Maximum
May 01 2023
20.35M
Average
7.174M
Median
Enterprise Value Benchmarks
| Affimed NV | 30.82M |
| BioNTech SE | 8.336B |
| Immatics NV | 314.32M |
| CureVac NV | 394.66M |
| ATAI Life Sciences NV | 157.38M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.91M |
| Revenue (Quarterly) | 0.0068M |
| Total Expenses (Quarterly) | 16.59M |
| EPS Diluted (Quarterly) | -0.2584 |
| Gross Profit Margin (Quarterly) | -5.38K% |
| Profit Margin (Quarterly) | -217.8K% |
| Earnings Yield | -43.55% |
| Normalized Earnings Yield | -44.54 |